Drug-labels.com

Zym-Amlodipine: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
5.0 mg, 10.0 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - Zym-Amlodipine

ABOUT THIS MEDICATION

What the medication is used for:

Zym-AMLODIPINE has been prescribed to you for the treatment of mild to moderate essential hypertension (high blood pressure) or for the management of chronic stable angina (chest pain).

What it does:

Zym-AMLODOPINE relaxes the blood vessels that carry blood away from the heart and increases the supply of blood and oxygen to the heart, while reducing its workload.

When it should not be used:

You should not use Zym-AMLODIPINE if you:

C are hypersensitive to this drug or other

dihydropyridines, or to any ingredient in the formulation or component of the container (consult list of non-medicinal ingredients). C have a low blood pressure (less than 90 mmHg

systolic).

What the medicinal ingredient is:

Amlodipine Besylate

What the nonmedicinal ingredients are:

Dibasic calcium phosphate anhydrous, Magnesium stearate, Microcrystalline Cellulose and Sodium starch glycolate.

What dosage forms it comes in:

Tablets: 5 mg & 10 mg amlodipine (from amlodipine besylate)

WARNINGS AND PRECAUTIONS

BEFORE you use Zym-AMLODIPINE, talk to your doctor or pharmacist if you / the patient you are caring for:

  • have/has a history of stroke, mini-strokes or high cholesterol;
  • have/has a history of kidney or liver problems;
  • have/has a history of problems with your heart and/or blood vessels;
  • are/is pregnant or planning to become pregnant;

  • are/is breast-feeding;
  • are taking or planning to take any other medicines (prescription, over-the-counter medicines or herbal remedies);
  • drink/drinks alcoholic beverages or use/uses drugs.

Beta-blocker withdrawal:

Zym-AMLODIPINE should be discontinued gradually by slowly reducing the dose of the drug.

Use in Children: The use of Zym-AMLODIPINE is not recommended in children less than 6 years of age.

Use in the elderly: Adverse reactions include swelling, muscle cramps and dizziness. Zym-AMLODIPINE should be used cautiously in elderly patients.

INTERACTIONS WITH THIS MEDICATION

If you are taking any medication, prescription, non-prescription and/or herbal, please inform your doctor before starting treatment with this medicine. Concomittant use of Zym-AMLODIPINE with other drugs may require surveillance and dosage adjustments.

Taking amlodipine with other drugs which are eliminated by the body through the same mechanism may result in altered bioavailability of amlodipine or these drugs. Dosages of similarly metabolized drugs, and especially in patients with renal and/or hepatic impairment, may require adjustment when starting or stopping medication.

Medications known or susceptible to interact with this medication include: azole antifungals, cimetidine, cyclosporine, erythromycin, quinidine, terfenadine, warfarin, Phenobarbital, phenytoin, rifampin, benzodiazepines, flecainide, imipramine, propafenone and theophylline.

When beta-adrenergic receptor blocking drugs are administered concomitantly with amlodipine, patients should be carefully monitored since blood pressure lowering effect of beta-blockers may be augmented by amlodipine.

PROPER USE OF THIS MEDICATION

Take this medication exactly as prescribed by your physician. Do not stop taking your medication without having first informed your doctor.

The dose of Zym-AMLODIPINE will be different for different patients. Do not give it to anybody else, even if their condition seems similar to yours, as they may experience undesirable effects, which may be serious.

For both high blood pressure and chest pain, the initial dose of Zym-AMLODIPINE is 5 mg once daily. If necessary, the dose can be increased after 1-2 weeks to a maximum dose of 10 mg once daily.

Use in the Elderly or in Patients with Impaired Renal Function

The recommended initial dose in patients over 65 years of age or patients with impaired renal function is 5 mg once daily. If required, increasing in the dose should be done gradually and with caution (see WARNING AND PRECAUTIONS).

Use in Patients with Impaired Hepatic Function When Zym-AMLODIPINE is used in these patients, the dosage should be carefully and gradually adjusted depending on patients tolerance and response. A lower starting dose of 2.5 mg once daily should be considered (see WARNINGS AND PRECAUTIONS).

Use in Children

The effective antihypertensive oral dose in pediatric patients ages 6-17 years is 2.5 mg to 5 mg once daily.

Overdose

If you take / give too much, immediately contact the doctor or go / take the patient to the nearest hospital emergency department, Do this even if there are no signs of discomfort.

One or more of the following signs may occur in an overdose: low blood pressure and rapid heartbeat.

Missed Dose

If you miss a dose, try not to miss any more. DO NOT TAKE / GIVE TWO DOSES AT ONCE.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effects of Zym-AMLODIPINE are: edema (swelling), headache, fatigue, dizziness and nausea.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist

Only if

severe

In all cases

Edema

(swelling of the extremities)

/
headache/
fatigue/
dizziness/
nausea/

rapid or irregular

heartbeat

/
low blood pressure/
liver problems such as jaundice (yellowing of skin or eyes)/

symptoms of allergic

reactions

/

This is not a complete list of side effects. If you have any unexpected effects while taking this drug, contact your doctor or pharmacist.

REPORTING SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

$ Report online at

www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345

$ Complete a Canada Vigilance Reporting

Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program Health Canada

    Postal Locator 0701C Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at

www.healthcanada.gc.ca/medeffect .

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

HOW TO STORE IT

  • Do not use this product after the expiry date written on the package.
  • Store between 15-30°C, protected from light.
  • Keep this and all medicines in a safe place away from children.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be obtained by contacting Zymcan Pharmaceuticals Inc.:

By post: Zymcan Pharmaceuticals Inc. 6111 avenue Royalmount, #100 Montreal, QC H4P 2T4

Zymcan Pharmaceuticals Inc.

Date of Preparation: April 1, 2010.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02342790

Revision date stated in the text: April 1, 2010

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Zym-Amlodipine

Rx or OTC
Prescription (Rx)?
DIN 02342790, 02342804
Schedule(s) PRESCRIPTION
Active ingredient(s) Amlodipine (amlodipine besylate)
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C08 Calcium channel blockers
      1. C08C Selective calcium channel blockers with mainly vascular effects
        1. C08CA Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects
          1. C08CA01 Amlodipine
Company ZYMCAN PHARMACEUTICALS INC
Current status Cancelled Post Market
Current status date June 16, 2014
Strengths and forms
DIN Strength Dosage form(s) Current status
02342790 5.0 MG Tablet Cancelled Post Market June 16, 2014
02342804 10.0 MG Tablet Cancelled Post Market June 16, 2014

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.